Hematuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
235
|
31
|
0.100 |
None |
|
0 |
|
|
|
Hemoperitoneum
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Pathologic Function
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Oral cavity bleeding
|
phenotype |
|
Pathologic Function
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Muscle hematoma
|
disease |
Pathological Conditions, Signs and Symptoms
|
Injury or Poisoning
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Spontaneous hematomas
|
disease |
|
Disease or Syndrome
|
33
|
|
0.100 |
None |
|
0 |
|
|
|
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Postpartum Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the musculature
|
phenotype |
|
Anatomical Abnormality
|
24
|
|
0.100 |
None |
|
0 |
|
|
|
Reduced factor X activity
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Partial thromboplastin time increased (finding)
|
phenotype |
|
Finding
|
18
|
1
|
0.100 |
None |
|
0 |
|
|
|
Antepartum hemorrhage affecting fetus or newborn
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Gastrointestinal Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Pathologic Function
|
122
|
24
|
0.100 |
None |
|
0 |
|
|
|
Abnormal umbilical stump bleeding
|
disease |
|
Anatomical Abnormality
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Antepartum hemorrhage
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Epistaxis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Pathologic Function
|
82
|
4
|
0.100 |
None |
|
0 |
|
|
|
Prolonged bleeding after surgery
|
phenotype |
|
Pathologic Function
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Increased tendency to bruise
|
phenotype |
Wounds and Injuries
|
Finding
|
133
|
14
|
0.100 |
None |
|
0 |
|
|
|
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.090 |
None |
0.889 |
9 |
|
2018 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.090 |
None |
0.889 |
9 |
|
2018 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.080 |
None |
0.875 |
8 |
|
2005 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.060 |
None |
1.000 |
6 |
|
2000 |
2019 |
Activated Protein C Resistance
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
41
|
30
|
0.060 |
None |
1.000 |
6 |
|
1995 |
2017 |
Embolic stroke of undetermined source
|
disease |
|
Disease or Syndrome
|
4
|
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Hemophilia, NOS
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
82
|
8
|
0.050 |
None |
1.000 |
5 |
|
2011 |
2019 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2019 |